APVO — Aptevo Therapeutics Share News
0.000.00%
Last trade - 00:00U.S. STOCKS ON THE MOVE-Principal Financial Group, NetApp
U.S. STOCKS ON THE MOVE-Genesco, Fervo Energy, Tyson Foods
Aptevo Therapeutics reports early data for blood cancer therapy; shares fall
Aptevo Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Aptevo Therapeutics Inc expected to post a loss of $6.01 a share - Earnings Preview
Brief: Aptevo Therapeutics - Announces New Solid Tumor Strategy - SEC Filing
Brief: Aptevo Therapeutics Inc - Marvin White To Retire As Aptevo CEO Effective April 1, 2026 - SEC Filing
Brief: Aptevo Therapeutics Prospectus Relates To Offer And Sale Of Up To 7,075,471 Shares Of Our Common Stock By Selling Stockholder
Brief: Aptevo Therapeutics On Jan 8, Enters Equity Purchase Agreement With Ya Ii Pn, Ltd
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Aptevo Therapeutics Inc Announces 1-For-18 Reverse Stock Split
Aptevo Therapeutics Q3 net loss widens to $7.5 mln
U.S. STOCKS ON THE MOVE- Jefferies Financial, Amer Sports
U.S. STOCKS ON THE MOVE-GE Healthcare ,Intellia, Bullish
U.S. STOCKS ON THE MOVE-Intel, Nike, Aptevo
Aptevo soars after billionaire investor discloses stake
Aptevo jumps after blood cancer therapy shows 100% remission in trial
Aptevo Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary